Review uncovers engineered exosomes' potential for improved targeting and therapeutic efficacy in clinical applications, suggesting significant advancements in drug delivery.
Key Points
Engineered exosomes improve targeting precision and stability compared to conventional exosomes.
Advanced drug-loading technologies enhance delivery efficiency and therapeutic safety for various diseases.
Innovative modifications address limitations in targeting and therapeutic effects of natural exosomes.
Standardization of production processes and long-term biosafety assessment remain key challenges for clinical use.